Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Gross Margin (2010 - 2013)

Updated

Northwest Biotherapeutics' Gross Margin was 100.00% in FY2013, unchanged from 100.00% in FY2012.

Analysis

Northwest Biotherapeutics (NWBO) Gross Margin (2010 - 2013) Analysis & Trends

From FY2010 onward, Northwest Biotherapeutics has reported Gross Margin for 4 years.

  • Gross Margin shows a three-year change of 0.00 percentage points (FY2010 to FY2013).
  • Per Business Quant data, Gross Margin in earlier years was 100.00% in FY2012 (unchanged), 100.00% in FY2011 (unchanged) and 100.00% in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 68.19%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 74.74%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 73.54%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 78.02%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 83.60%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 72.04%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 79.76%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 72.78%
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 100.00%
Jun 30, 2013 100.00%
Mar 31, 2013 100.00%
Dec 31, 2012 100.00%
Sep 30, 2012 100.00%
Jun 30, 2012 100.00%
Sep 30, 2011 100.00%
Sep 30, 2010 100.00%
API Access

Northwest Biotherapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=NWBO&period=max&api_key=YOUR_API_KEY